ArticleFrontiers in public health2024

Toripalimab plus chemotherapy in the treatment of metastatic triple-negative breast cancer: a cost-effectiveness analysis.

Hongfu Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.